Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

FTXH vs DLHIX overlap: 44% of top holdings shared

Bottom line

How much do FTXH and DLHIX overlap?

44% of their top holdings overlap by weight. 13 securities appear in both funds' top 25, making up 46.9% of FTXH's assets and 37.5% of DLHIX's. They share a meaningful core but differ in the rest of the portfolio.

DLHIX holds far more positions (108 vs 51), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

FTXHDLHIX
Weight overlap (top 25)44%
Shared holdings13
Weight in shared holdings46.9%37.5%
Total positions51108
Expense ratio0.6%0.96%
Holdings as ofJun 30, 2026Jun 30, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Holdings FTXH and DLHIX have in common

Holding% of FTXH% of DLHIXOverlap
Eli Lilly & Company LLY7.77%4.16%4.16%
Abbvie Inc ABBV7.39%4.19%4.19%
Merck & Company Inc MRK7.07%3.68%3.68%
Viatris Inc VTRS3.62%2.48%2.48%
Vertex Pharmaceuticals Inc VRTX3.41%1.66%1.66%
Amgen Inc AMGN3.18%2.27%2.27%
Pfizer Inc PFE2.97%3.84%2.97%
Gilead Sciences Inc GILD2.89%3.54%2.89%
Regeneron Pharmaceuticals Inc REGN2.72%3.91%2.72%
Illumina Inc ILMN1.98%2.11%1.98%
Neurocrine Biosciences Inc NBIX1.37%1.57%1.37%
Alkermes Plc ALKS1.35%1.82%1.35%
Halozyme Therapeutics Inc HALO1.21%2.30%1.21%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in FTXH

  1. Johnson & Johnson — 6.96%
  2. Bristol-myers Squibb Company — 6.29%
  3. Biogen Inc — 3.84%
  4. Cardinal Health Inc — 3.53%
  5. United Therapeutics Corp — 2.72%
  6. Jazz Pharmaceuticals Plc — 2.49%
  7. Incyte Corp — 2.39%
  8. Zoetis Inc — 1.87%
  9. Exelixis Inc — 1.72%
  10. Charles River Laboratories International Inc — 1.49%
  11. Medpace Holdings Inc — 1.41%
  12. Ptc Therapeutics Inc — 1.37%

Only in DLHIX

  1. Ucb Sa — 5.19%
  2. Unitedhealth Group Inc — 3.88%
  3. Astrazeneca Plc — 3.27%
  4. Elevance Health Inc — 3.25%
  5. Roche Holding Ag — 3.01%
  6. Chugai Pharmaceutical Co Ltd — 2.77%
  7. Oruka Therapeutics Inc — 2.41%
  8. Viking Therapeutics Inc — 1.72%
  9. Roivant Sciences Ltd — 1.60%
  10. Arcus Biosciences Inc — 1.56%
  11. Zimmer Biomet Holdings Inc — 1.42%
  12. Boston Scientific Corp — 1.42%

Asset mix

Asset typeFTXHDLHIX
Stocks99.9%94.8%
Preferred stock—3.0%
Cash & short-term funds0.1%2.0%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Country mix

CountryFTXHDLHIX
US95.6%75.4%
BE—5.2%
IE3.8%3.2%
GB—3.3%
CH—3.0%
JP—2.8%
FR—2.0%
NL—1.6%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Check another pair

FAQ

How much do FTXH and DLHIX overlap?
About 44% by weight. 13 securities appear in both funds' top 25 holdings; they make up 46.9% of FTXH's assets and 37.5% of DLHIX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do FTXH and DLHIX have in common?
The largest shared holdings are Abbvie Inc, Eli Lilly & Company, Merck & Company Inc, Pfizer Inc, Gilead Sciences Inc.
Should I own both FTXH and DLHIX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, FTXH or DLHIX?
DLHIX is broader, with 108 positions versus 51 for FTXH. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.